| | |
ACTUAL TREATMENT
|
|---|
|
AASLD INDICATIONS
| |
RESECTION
|
OLTx
|
PEI/RFTA
|
TACE
|
BSC
|
|---|
| |
RESECTION
|
5 (13%)
|
1(2%)
|
24(59%)
|
10(24%)
|
1(2%)
|
| |
OLTx
|
2(33%)
|
2(33%)
|
-
|
2(33%)
|
-
|
| |
PEI or RFTA
|
1(7%)
|
-
|
6(46%)
|
4(31%)
|
2(16%)
|
- OLTx: orthotopic liver transplantation; RFTA: radiofrequency-mediated thermal ablation;
- PEI: percutaneous ethanol injection; TACE: transcatheter arterial chemoembolization; BSC: best supportive care
- AASLD indications for treatment are reported in rows; percentages of patients treated per each modality are calculated on the totality of patients having that specific indication.
- The adherence to AASLD indication was evaluated when all data were available (60/65 pts – 91%).
